First Quarter 2015 Highlights
- Revenues of $20.4 million, exceeding guidance by 17%.
- Adjusted earnings* of $ 6.8 million, or 6 cents per basic share, exceeding the high end of guidance by 112%.
- Signed eight licenses including two licenses with Texas Instruments, a license with Covidien related to medical stent technology and two wireless license renewals.
- Acquired a patent portfolio from a major global semiconductor company related to semiconductor power management.
- Returned $5.2 million to shareholders in dividend payments.